IP Library › Patent Application 62509683
Patent Application Provisional
App. No. 62/509,683 · Confirmation No. 5603

NALOXONE COMPOSITIONS PROVIDING ENHANCED ORAL BIOAVAILABILITY IN ABUSE-DETERRENT MULTIDOSE-PROTECTION OPIOID FORMULATIONS

Applicant: KASHIV PHARMA, LLC
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2018-01-18 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2018-01-12 PA.. Power of Attorney 1 View
2018-01-12 R3.73 Assignee showing of ownership per 37 CFR 3.73 3 View
2018-01-12 N417 Electronic Filing System Acknowledgment Receipt 2 View
2017-05-26 APP.FILE.REC Filing Receipt 3 View
2017-05-22 WFEE Fee Worksheet (SB06) 2 View
2017-05-22 N417 Electronic Filing System Acknowledgment Receipt 2 View
2017-05-22 TR.PROV Provisional Cover Sheet (SB16) 3 View
2017-05-22 ADS Application Data Sheet 9 View
2017-05-22 SPEC Specification 41 View
2017-05-22 CLM Claims 8 View
2017-05-22 ABST Abstract 1 View
2017-05-22 N417 Electronic Filing System Acknowledgment Receipt 2 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/509,683
Filed
2017-05-22